Loading...

Streamlined CFDA review process: New opportunities in China

Image

 Insights

01-Dec-17 The Draft Amendment by China's FDA brings some good news around the streamlined reviews of medical device submissions, especially for innovative device makers. Nevertheless, there still exist some challenges for the unwary. [image: Brandworld Biomedical]

Read More
Share